This is a fictional, illustrative case created for education. It is not medical advice, diagnosis, or treatment, and does not describe a real person.

He was told his risk. Nobody checked the form.

David, 58, was taking omega-3 and choline every day after learning he was APOE ε4/ε4. His labs stayed low. The mystery was not effort — it was the form his body could use.

Persona

David, 58, Male, Caribbean-British, Retired headteacher.

David learned 18 months ago that he carries two copies of APOE ε4. Since then he has been anxious, taking fish oil and choline daily, eating 'clean', and doing what his family doctor suggested. His latest cholesterol is still elevated and his omega-3 and choline levels are low. He wants to know whether he has been solving the wrong problem.

Family history: Father: vascular dementia, died aged 71. Paternal uncle: Alzheimer's disease, diagnosed aged 67. Mother: hypertension, no cognitive decline.

Clinical picture

Symptoms

Labs

Medications

Supplements

Lifestyle

Genetics

He got the risk label, then a blank page

Eighteen months ago, David saw three words from a commercial DNA test: APOE ε4/ε4. He read that it was the highest-risk APOE pattern for Alzheimer's and barely slept that night. His family doctor was sympathetic but had little to offer beyond keeping cardiovascular risk down. David did what he could: cleaned up his diet, walked most days, added fish oil and choline. His cholesterol is still elevated, and he feels more anxious than before.

The clue was in the supplements that did not show up

David is doing the things he was told might help: omega-3 fish oil, choline, clean eating. But two blood markers give the plot away. After 18 months of fish oil, his omega-3 index is still low. His choline is low too, even with daily pills. The problem is not effort. The forms he chose do not match the way his body processes them.

The fish oil was the wrong route

Most standard omega-3 advice assumes the body can convert what it takes in into the long-chain forms the brain uses. David's FADS1 variant makes that conversion inefficient, which helps explain the low omega-3 index after 18 months of supplementing. For someone with APOE ε4/ε4, DHA supply matters even more because the brain is less efficient at handling these fats. The fix is not simply more capsules. It is a more usable form.

The choline had the same problem

The choline supplement David takes also depends on conversion before the brain can use it. His PEMT variant makes that step less reliable, so a daily habit can still leave the useful form low. CDP-choline and alpha-GPC take a more direct route. Same category, different form, different expected result.

Four changes to discuss with his clinician

Which form changes the picture

David was already following the generic advice. The hidden issue was form: omega-3 and choline land differently depending on the route his body can use. APOE ε4/ε4 + FADS1 + PEMT baseline baseline 85%.

David's 14-day precision protocol check-in

Omega-3 switch · CDP-choline · daily oily fish. David switched his supplements in week 1 and added sardines three times a week. Subjective changes come before labs do — energy, mood, and mental sharpness are the early signals.

David's 8-week precision protocol goals

Daily: algae DHA + CDP-choline · Oily fish 3x/week. The supplements were easy to switch. The food habit took until week 4 to stick.